Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (81)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Creus, M.
Right arrow Articles by Balasch, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Creus, M.
Right arrow Articles by Balasch, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 11, 2341-2346, November 2000
© 2000 European Society of Human Reproduction and Embryology

Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome

Montserrat Creus1, Joana Peñarrubia1, Francisco Fábregues1, Ester Vidal1, Francisco Carmona1, Roser Casamitjana2, Juan A. Vanrell1 and Juan Balasch1,3

1 Institut Clínic of Gynecology, Obstetrics and Neonatology and 2 Hormonal Laboratory, Faculty of Medicine-University of Barcelona, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Recent reports investigating the value of basal inhibin B determination as a predictor of ovarian reserve and assisted reproduction treatment have led to discordant results. This study was undertaken to further assess the relative power of day 3 inhibin B and follicle stimulating hormone (FSH) (defined before treatment) and the woman's age both as single and combined predictors of ovarian response and pregnancy in an in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) programme. A total of 120 women undergoing their first cycle of IVF or ICSI was included. Forty consecutive cycles cancelled because of poor follicular response were initially selected. As a control group, the nearest completed IVF/ICSI cycles before and after each cancelled cycle (i.e. the closest cycles in temporal relationship to the index cycle) were used. Mean age and basal FSH concentrations were significantly higher in the cancelled than in the control group (P < 0.01 and P < 0.001 respectively), whereas basal inhibin B was significantly higher in the latter (P < 0.05). The association of basal FSH (with an accuracy or predictive value of ovarian response of 79%) with cancellation rate was significant, independent of, and stronger than the effects of age and inhibin B (P < 0.05). Any two or all three of these variables studied did not improve the predictive value of FSH alone. Woman's age was the only variable independently associated with pregnancy rate. It is concluded that the stronger predictors of success in patients undergoing their first IVF/ICSI treatment cycle are age and basal FSH rather than inhibin B. Basal FSH concentration was a better predictor of cancellation rate than age, but age was a stronger predictor of pregnancy rate.

Key words: assisted reproduction treatment/FSH/inhibin B/low responders/ovarian reserve

3 To whom correspondence should be addressed at: Institut Clínic of Gynecology, Obstetrics and Neonatology, Hospital Clínic,C/Casanova 143, 08036-Barcelona, Spain.E-mail: jbalasch{at}medicina.ub.es


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
F. Fabregues, J. Penarrubia, M. Creus, D. Manau, G. Casals, F. Carmona, and J. Balasch
Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial
Hum. Reprod., February 1, 2009; 24(2): 349 - 359.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
T.E.M. Verhagen, D.J. Hendriks, L.F.J.M.M. Bancsi, B.W.J. Mol, and F.J.M. Broekmans
The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis
Hum. Reprod. Update, March 1, 2008; 14(2): 95 - 100.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. B. Baart, E. Martini, M. J. Eijkemans, D. Van Opstal, N. G.M. Beckers, A. Verhoeff, N. S. Macklon, and B. C.J.M. Fauser
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial
Hum. Reprod., April 1, 2007; 22(4): 980 - 988.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. McIlveen, J.D. Skull, and W.L. Ledger
Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population
Hum. Reprod., March 1, 2007; 22(3): 778 - 785.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk
A systematic review of tests predicting ovarian reserve and IVF outcome
Hum. Reprod. Update, November 1, 2006; 12(6): 685 - 718.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Maheshwari, P. Fowler, and S. Bhattacharya
Assessment of ovarian reserve--should we perform tests of ovarian reserve routinely?
Hum. Reprod., November 1, 2006; 21(11): 2729 - 2735.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R.A. Anderson, A.P.N. Themmen, A.A. -Qahtani, N.P. Groome, and D.A. Cameron
The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer
Hum. Reprod., October 1, 2006; 21(10): 2583 - 2592.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Balasch, F. Fabregues, J. Penarrubia, F. Carmona, R. Casamitjana, M. Creus, D. Manau, G. Casals, and J. A. Vanrell
Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH
Hum. Reprod., July 1, 2006; 21(7): 1884 - 1893.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Endocr. Rev., April 1, 2006; 27(2): 170 - 207.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Abdalla and M.Y. Thum
Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH
Hum. Reprod., January 1, 2006; 21(1): 171 - 174.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Eldar-Geva, A. Ben-Chetrit, I. M. Spitz, R. Rabinowitz, E. Markowitz, T. Mimoni, M. Gal, E. Zylber-Haran, and E. J. Margalioth
Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome
Hum. Reprod., November 1, 2005; 20(11): 3178 - 3183.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Weghofer, M. Margreiter, Y. Fauster, T. Schaetz, A. Brandstetter, D. Boehm, and W. Feichtinger
Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction
Hum. Reprod., September 1, 2005; 20(9): 2448 - 2452.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Vujisic, F. Stipoljev, R. Bauman, R. Dmitrovic, and D. Jezek
Pericentric inversion of chromosome 2 in a patient with the empty follicle syndrome: Case report
Hum. Reprod., September 1, 2005; 20(9): 2552 - 2555.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. H. Y. Ng, C. C. W. Chan, O. S. Tang, and P. C. Ho
Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment
Hum. Reprod., June 1, 2005; 20(6): 1647 - 1654.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Penarrubia, F. Fabregues, D. Manau, M. Creus, G. Casals, R. Casamitjana, F. Carmona, J. A. Vanrell, and J. Balasch
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment
Hum. Reprod., April 1, 2005; 20(4): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. P Hohmann, J. S E Laven, F. H de Jong, and B. C J M Fauser
Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women
Eur. J. Endocrinol., March 1, 2005; 152(3): 395 - 401.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
K. Lutchman Singh, M. Davies, and R. Chatterjee
Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing
Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L.E. Bath, G. Tydeman, H.O.D. Critchley, R.A. Anderson, D.T. Baird, and W.H.B. Wallace
Spontaneous conception in a young woman who had ovarian cortical tissue cryopreserved before chemotherapy and radiotherapy for a Ewing's sarcoma of the pelvis: Case report
Hum. Reprod., November 1, 2004; 19(11): 2569 - 2572.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L.E. Bath, W.H.B. Wallace, M.P. Shaw, C. Fitzpatrick, and R.A. Anderson
Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound
Hum. Reprod., November 1, 2003; 18(11): 2368 - 2374.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. H. Y. Ng, W. S. B. Yeung, D. Y. T. Fong, and P. C. Ho
Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility
Hum. Reprod., October 1, 2003; 18(10): 2169 - 2174.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. C. Chu, K. M. Rath, J. Huie, and H. S. Taylor
Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk
Hum. Reprod., August 1, 2003; 18(8): 1570 - 1573.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G.J. Scheffer, F.J.M. Broekmans, C.W.N. Looman, M. Blankenstein, B.C.J.M. Fauser, F.H. de Jong, and E.R. te Velde
The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age
Hum. Reprod., April 1, 2003; 18(4): 700 - 706.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Y.K. Yong, D. T. Baird, K.J. Thong, A. S. McNeilly, and R. A. Anderson
Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation
Hum. Reprod., January 1, 2003; 18(1): 35 - 44.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Platteau, K. Sermon, S. Seneca, A. Van Steirteghem, P. Devroey, and I. Liebaers
Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossible
Hum. Reprod., November 1, 2002; 17(11): 2807 - 2812.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Eldar-Geva, E.J. Margalioth, A. Ben-Chetrit, M. Gal, D.M. Robertson, D.L. Healy, Y.Z. Diamant, and I.M. Spitz
Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders
Hum. Reprod., September 1, 2002; 17(9): 2331 - 2337.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C.-L. Chang, T.-H. Wang, S.-G. Horng, H.-M. Wu, H.-S. Wang, and Y.-K. Soong
The concentration of inhibin B in follicular fluid: relation to oocyte maturation and embryo development
Hum. Reprod., July 1, 2002; 17(7): 1724 - 1728.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Fawzy, A. Lambert, R.F. Harrison, P.G. Knight, N. Groome, B. Hennelly, and W.R. Robertson
Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome
Hum. Reprod., June 1, 2002; 17(6): 1535 - 1543.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. D.L. Hundscheid, D. D.M. Braat, L. A.L.M. Kiemeney, A. P.T. Smits, and C. M.G. Thomas
Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives
Hum. Reprod., March 1, 2001; 16(3): 457 - 462.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.